A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

Clinical trial NCT06655155 · RECRUITING

Trial details

NCT number: NCT06655155
Sponsor: argenx
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Sclerosis (SSc)

Start date: 2024-11-11
Primary completion: 2027-02-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.